Cognex (CGNX) VP sells shares after multiple option exercises
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cognex Corp VP and PAO Laura Ann Macdonald reported a series of option exercises paired with open‑market sales of Common Stock on May 11–12, 2026. She sold a total of 139,722 shares of Common Stock in open‑market transactions at prices including $66.8022 and $65.5632 per share.
These sales followed exercises of stock options covering 137,510 shares at strike prices ranging from $33.04 to $56.44 per share. After the transactions, she holds 5,258 Common shares directly, plus equity awards such as Restricted Stock Units and Non‑Qualified Stock Options, including 11,211 RSUs and options for 23,891 shares at an exercise price of $64.43. An additional 20 shares are held indirectly by her child, for which she disclaims beneficial ownership except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 139,722 shares ($9,282,195)
Net Sell
36 txns
Insider
MACDONALD LAURA ANN
Role
VP and PAO
Sold
139,722 shs ($9.28M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 6,100 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 10,000 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 25,500 | $0.00 | -- |
| Exercise | Common Stock | 6,100 | $47.21 | $288K |
| Sale | Common Stock | 6,100 | $65.5632 | $400K |
| Exercise | Common Stock | 10,000 | $48.28 | $483K |
| Sale | Common Stock | 10,000 | $65.5632 | $656K |
| Exercise | Common Stock | 25,500 | $50.94 | $1.30M |
| Sale | Common Stock | 25,500 | $65.5632 | $1.67M |
| Exercise | Non-Qualified Stock Option (right to buy) | 6,634 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 15,080 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 12,196 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 17,000 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 30,000 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 15,000 | $0.00 | -- |
| Exercise | Common Stock | 6,634 | $33.04 | $219K |
| Sale | Common Stock | 6,634 | $66.8022 | $443K |
| Exercise | Common Stock | 15,080 | $39.44 | $595K |
| Sale | Common Stock | 15,080 | $66.8022 | $1.01M |
| Exercise | Common Stock | 12,196 | $47.21 | $576K |
| Sale | Common Stock | 12,196 | $66.8022 | $815K |
| Exercise | Common Stock | 17,000 | $50.94 | $866K |
| Sale | Common Stock | 17,000 | $66.8022 | $1.14M |
| Exercise | Common Stock | 30,000 | $51.49 | $1.54M |
| Sale | Common Stock | 30,000 | $66.8022 | $2.00M |
| Exercise | Common Stock | 15,000 | $56.44 | $847K |
| Sale | Common Stock | 15,000 | $66.8022 | $1.00M |
| Sale | Common Stock | 2,212 | $66.8022 | $148K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 12,196 shares (Direct, null);
Common Stock — 11,358 shares (Direct, null);
Restricted Stock Unit — 3,169 shares (Direct, null);
Common Stock — 20 shares (Indirect, By Child)
Footnotes (1)
- Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025). The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2024). The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 21, 2023). The options vest 100% on the third anniversary of the grant date (May 1, 2019). The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2020). The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019). The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018).
Key Figures
Shares sold: 139,722 shares
Shares exercised: 137,510 shares
Sale price example 1: $66.8022 per share
+5 more
8 metrics
Shares sold
139,722 shares
Total open-market sales of Cognex Common Stock
Shares exercised
137,510 shares
Total shares from exercised options (M-code transactions)
Sale price example 1
$66.8022 per share
Common Stock sale price on May 11, 2026
Sale price example 2
$65.5632 per share
Common Stock sale price on May 12, 2026
Direct shares after transactions
5,258 shares
Common Stock directly owned following reported trades
RSU position
11,211 underlying shares
Restricted Stock Units expiring February 17, 2029
Option position
23,891 underlying shares
Non-Qualified Stock Option at $64.43, expiring February 22, 2032
High strike option
$90.50 exercise price
Non-Qualified Stock Option for 13,946 underlying shares, expiring February 16, 2031
Key Terms
Non-Qualified Stock Option (right to buy), Restricted Stock Unit, open-market sale, derivative exercise/conversion, +2 more
6 terms
Non-Qualified Stock Option (right to buy) financial
"security_title: "Non-Qualified Stock Option (right to buy)" with underlying Common Stock"
Restricted Stock Unit financial
"security_title: "Restricted Stock Unit" with underlying Common Stock and 0.0000 exercise price"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
open-market sale financial
"transaction_action: "open-market sale" at prices like 66.8022 per share"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion" for M-code option exercises"
pecuniary interest financial
"footnote: reporting person disclaims beneficial ownership except to the extent of her pecuniary interest"
Section 16 regulatory
"footnote: not deemed an admission of beneficial ownership for purposes of Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
FAQ
What insider transactions did Cognex (CGNX) report for VP Laura Macdonald?
Laura Ann Macdonald reported option exercises and related share sales. She exercised stock options for 137,510 Cognex shares, then sold 139,722 Common shares in open‑market trades at prices around $66–$65 per share over May 11–12, 2026.
What ongoing equity awards does the Cognex (CGNX) VP still have?
She retains Restricted Stock Units and stock options in Cognex. Remaining awards include RSUs representing 11,211 and 9,685 underlying shares, plus Non‑Qualified Stock Options for 13,946, 23,891, and 7,231 underlying shares at exercise prices from $57.09 to $90.50.